cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Agus Prima
Contact Email
chairman@jsocmed.org
Phone
+6281269200232
Journal Mail Official
chairman@jsocmed.org
Editorial Address
Jl. DR. Wahidin Sudiro Husodo No.243B, Kembangan, Klangonan, Kec. Kebomas, Kabupaten Gresik, Jawa Timur 61124
Location
Kab. gresik,
Jawa timur
INDONESIA
The Journal of Society Medicine (JSOCMED)
Published by PT. CoinReads Media Prima
ISSN : -     EISSN : 29645565     DOI : https://doi.org/10.47353/jsocmed.v2i1
Core Subject : Health, Science,
Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience
The Journal of Society Medicine (JSOCMED) | ISSN (e): 2964-5565 is a leading voice in the Indonesia and internationally for medicine and healthcare. Published continuously, JSOCMED features scholarly comment and clinical research. JSOCMED is editorially independent from and its The Editor-in-Chief (EIC) is Prof. dr. Aznan Lelo, PhD, SpFK. JSOCMED offers many attractive features for authors, including free online access to all research articles, online publication ahead of print, and online responses to articles published as Quick Comments. In addition, as befitting a publication of the Journal of Society Medicine, JSOCMED implements best practice in scientific publishing with an open peer review process, declarations of competing interests and funding, full requirements for patient consent and ethical review, and statements of guarantorship, contributorship, and provenance.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 4 No. 3 (2025): March" : 5 Documents clear
Management of A Preeclampsia Patient with Diabetic Ketoacidosis and Acute Pulmonary Edema : A Case Report Fransisca, Arna; Pison , Osmond Muftilov
Journal of Society Medicine Vol. 4 No. 3 (2025): March
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i3.196

Abstract

Introduction: Preeclampsia is a hypertensive disorder that develops after 20 weeks of gestation, often accompanied by proteinuria and maternal organ dysfunction, including pulmonary edema. Women with diabetes are at a higher risk for developing preeclampsia and its complications. Managing severe preeclampsia requires prompt monitoring and intervention, particularly when organ failure and metabolic disturbances are present. Case Report: A 25-year-old pregnant woman at 30-31 weeks of gestation presented with severe dyspnea, high blood pressure (185/105 mmHg), and metabolic disturbances, including diabetic ketoacidosis (DKA) and pulmonary edema. The patient had no prior history of hypertension or diabetes. Laboratory tests revealed elevated ketones, hyponatremia, and mild proteinuria. She was admitted to the ICU, where she received nitroglycerin infusion, fluid resuscitation, and blood glucose regulation. However, her condition worsened, and she required intubation and mechanical ventilation due to severe hypoxemia and respiratory failure. After stabilization, a cesarean section was performed, leading to improvements in her condition. The patient was extubated after three days, and her blood glucose levels were stabilized. Conclusion: This case highlights the complexities of managing severe preeclampsia complicated by pulmonary edema, diabetic ketoacidosis, and urinary tract infections. Early recognition, aggressive treatment, and multidisciplinary care are essential for improving outcomes and preventing further complications in high-risk pregnancies.
Analysis of Blood Eosinophil Levels as an Indicator of Controlled Asthma Classification at the University of Sumatra Utara Hospital Damanik, Rizki Amaliah; Pradana, Andika; Pandia, Pandiaman
Journal of Society Medicine Vol. 4 No. 3 (2025): March
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i3.198

Abstract

Introduction: Asthma is a chronic inflammatory disease of the airways characterized by variable airflow obstruction. Eosinophils play a crucial role in airway inflammation and may serve as a biomarker for asthma control classification. This study aims to analyze the relationship between blood eosinophil levels and asthma control classification in patients at the University of Sumatra Utara Hospital. Methods: This was an analytical observational study with a retrospective cohort approach based on medical records. A total of 25 stable asthma patients who had been receiving inhaled corticosteroid-long-acting beta-agonist (ICS-LABA) therapy for at least one year were included. Data were analyzed using SPSS version 26, and the Kruskal-Wallis test was performed to assess the relationship between eosinophil levels and asthma control classification. Results: The majority of patients were aged 26-50 years (44%) and female (80%). Most patients had eosinophil levels <100 (84%), while 8% had levels between 100-300 and another 8% had levels >300. Regarding asthma control, 46.7% of patients were fully controlled, 43.3% were partially controlled, and 10% were uncontrolled. Statistical analysis showed a significant relationship between eosinophil levels and asthma control classification (p = 0.009), indicating that lower eosinophil levels are associated with better asthma control. Conclusion: The study found that lower eosinophil levels were associated with better asthma control. These findings suggest that blood eosinophil levels may serve as an indicator for assessing asthma control, though further research is needed to confirm this relationship.
The Relationship Between Low-Density Lipoprotein Cholesterol and Coronary Artery Calcium Score in Patients with Chronic Coronary Syndrome Without Diabetes Mellitus at RSUP Haji Adam Malik Medan Muslim, Suci Asriri Pradina; Lubis , Hilfan Ade Putra; Nasution , Ali Nafiah
Journal of Society Medicine Vol. 4 No. 3 (2025): March
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i3.203

Abstract

Introduction: Chronic Coronary Syndrome (CCS) is the most common symptom of ischemic heart disease and is a major cause of morbidity and mortality worldwide. One of the associated risk factors for coronary heart disease events is Low Density Lipoprotein Cholesterol (LDL-C) through the process of atherosclerosis. Computed Tomography Coronary Artery (CTCA) is an examination that can be performed to assess atherosclerotic plaques and Coronary Artery Calcium Score (CAC Score). This study was conducted to assess the relationship between LDL and CAC Score in CCS patients. Methods: This study is an observational analytical study involving 300 patients diagnosed with CCS during the period from March 1, 2023, to March 31, 2024, at RSUP H. Adam Malik Medan. All involved patients underwent LDL examination and CTCA examination as well as CAC Score measurement. Patient characteristics, disease history, and risk factors were also recorded. Results: There was a significant relationship between LDL levels and CAC Score (P value: 0.008; OR: 1.91 (CI: 1.184-3.1). Among the patient characteristics in this study, the strongest protective factor was female gender (P value: <0.01; OR: 0.228 (CI: 0.119-0.437)), and the strongest risk factor was patients with hypertension (P value: 0.017; OR: 1.97 (CI: 1.119-3.484). Conclusion: LDL can increase CAC Score in CCS patients.
The TIMI Risk Index as a Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention at Haji Adam Malik Hospital Medan Purba, Antonius Leonardo; Hasan, Refli; Raynaldo, Abdul Halim
Journal of Society Medicine Vol. 4 No. 3 (2025): March
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i3.204

Abstract

Introduction: ST-segment elevation myocardial infarction (STEMI) is a severe cardiovascular condition requiring urgent treatment through Primary Percutaneous Coronary Intervention (PPCI). However, PPCI increases the risk of Contrast-Induced Nephropathy (CIN), a condition characterized by a significant rise in serum creatinine levels. To minimize the risk of CIN, identifying patients at high risk is essential. This study evaluates the TIMI Risk Index (TRI) as a predictor of CIN in STEMI patients undergoing PPCI at Haji Adam Malik Hospital, Medan. Methods: This observational analytical study employed a cross-sectional design, focusing on STEMI patients with symptoms lasting less than 12 hours who underwent PPCI between January 2023 and December 2024. Participants were selected according to inclusion and exclusion criteria. Bivariate analysis was used, with the chi-square test for normally distributed data and the Fisher exact test for non-normally distributed data, with a significance level of p < 0.05. Results: The results indicated that TRI effectively predicted CIN occurrence, with a p-value of 0.0001, an area under the curve (AUC) of 0.834, and a 95% confidence interval (CI) of 0.752–0.916. A TRI cut-off score of 23.47 demonstrated a sensitivity of 77.3%, specificity of 77%, a positive predictive value (PPV) of 47.05%, and a negative predictive value (NPV) of 91.8%. Conclusion: In conclusion, the TRI with a cut-off score of 23.47 is a reliable tool for predicting CIN in STEMI patients undergoing PPCI, offering high sensitivity, specificity, and NPV, which can help improve clinical outcomes by identifying at-risk patients.
The Relationship Between Platelet and Lymphocyte Ratios and Left Atrial Thrombus Formation in Patients with Severe Mitral Stenosis due to Rheumatic Heart Disease at Haji Adam Malik Hospital Medan Ramzi, Defriyan; Hasan, Harris; Raynaldo, Abdul Halim
Journal of Society Medicine Vol. 4 No. 3 (2025): March
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i3.205

Abstract

Introduction: Rheumatic heart disease is an immune disease condition that often causes damage to the structure of the heart valves, such as mitral stenosis. One of the complications of severe mitral stenosis is thrombus in the left atrium. This condition is closely related to inflammation, so inflammatory cells such as lymphocytes and platelets are closely related to their severity and complications. Therefore, this study aims to see the ability of mitral platelet and lymphocyte ratios to the incidence of left atrial thrombus. Methods: This study is an analytical descriptive study with a cross-sectional research design, conducted at the Integrated Heart Center of Haji Adam Malik Hospital, from November 2024. The parameters of echocardiography, blood laboratory, as well as thrombus in the left atrium data were acquired. A statistical analysis test will be was done to assess the difference in the average ratio of platelets and lymphocytes based on the presence of thrombus in the left atrium, as well as the ability of the predictor of the ratio. Statistical analysis was carried out using SPSS software, a P value of < 0.05 was considered significant. Results: There are a total of 175 samples in this study. A total of 45 (25.7%) of the sample had thrombus in the left atrium. The median value and interquartile range of the Platelet/Lymphocyte Ratio (PLR) were higher in the thrombus group in the left atrium compared to the group without thrombus in the left atrium (P = 0.0001). The ROC curve analysis showed PLR parameters, with P = 0.0001, AUC 0.713, and 95% CI 0.620 – 0.806. The threshold value of PLR 132.5 has a sensitivity of 71.1% and a specificity of 61.0% has the ability to predict the presence of thrombus in the left atrium. Conclusion: The PLR ratio has a significant association with the occurrence of thrombus in the left atrium, in the condition of severe mitral stenosis due to rheumatic heart disease

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue Vol. 4 No. 12 (2025): December Vol. 4 No. 11 (2025): November Vol. 4 No. 10 (2025): October Vol. 4 No. 9 (2025): September Vol. 4 No. 8 (2025): August Vol. 4 No. 7 (2025): July Vol. 4 No. 6 (2025): June Vol. 4 No. 5 (2025): May Vol. 4 No. 4 (2025): April Vol. 4 No. 3 (2025): March Vol. 4 No. 2 (2025): February Vol. 4 No. 1 (2025): January Vol. 3 No. 12 (2024): December Vol. 3 No. 11 (2024): November Vol. 3 No. 10 (2024): Oktober Vol. 3 No. 9 (2024): September Vol. 3 No. 8 (2024): August Vol. 3 No. 7 (2024): July Vol. 3 No. 6 (2024): June Vol. 3 No. 5 (2024): May Vol. 3 No. 4 (2024): April Vol. 3 No. 3 (2024): March Vol. 3 No. 2 (2024): February Vol. 3 No. 1 (2024): January Vol. 2 No. 12 (2023): December Vol. 2 No. 11 (2023): November Vol. 2 No. 10 (2023): October Vol. 2 No. 9 (2023): September Vol. 2 No. 8 (2023): August Vol. 2 No. 7 (2023): July Vol. 2 No. 6 (2023): June Vol. 2 No. 5 (2023): May Vol. 2 No. 4 (2023): April Vol. 2 No. 3 (2023): March Vol. 2 No. 2 (2023): February Vol. 2 No. 1 (2023): January Vol. 1 No. 3 (2022): December Vol. 1 No. 2 (2022): November Vol. 1 No. 1 (2022): October More Issue